{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:56:02Z","timestamp":1791021362240,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["4078P0-198470"],"award-info":[{"award-number":["4078P0-198470"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030B_182834"],"award-info":[{"award-number":["310030B_182834"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_204835"],"award-info":[{"award-number":["310030_204835"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jidinnovations.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JID Innovations"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.xjidi.2026.100499","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:02:49Z","timestamp":1780617769000},"page":"100499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immune shifts in inflammatory skin diseases"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4267-5734","authenticated-orcid":false,"given":"Hugo","family":"Cometto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9776-6370","authenticated-orcid":false,"given":"Fanny","family":"Saidoune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6281-3918","authenticated-orcid":false,"given":"Jeremy","family":"Di Domizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4609-3762","authenticated-orcid":false,"given":"Michel","family":"Gilliet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xjidi.2026.100499_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.932766","article-title":"Case report: clinical and histopathological characteristics of psoriasiform erythema and de novo IL-17A cytokines expression on lesioned skin in atopic dermatitis children treated with dupilumab","volume":"9","author":"Ali","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.xjidi.2026.100499_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jamadermatol.2023.4846","article-title":"Risk of paradoxical eczema in patients receiving biologics for psoriasis","volume":"160","author":"Al-Janabi","year":"2024","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.xjidi.2026.100499_bib3","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20231464","article-title":"Human neutrophils drive skin autoinflammation by releasing interleukin (IL)-26","volume":"221","author":"Baldo","year":"2024","journal-title":"J Exp Med"},{"key":"10.1016\/j.xjidi.2026.100499_bib4","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMra074081","article-title":"Atopic dermatitis","volume":"358","author":"Bieber","year":"2008","journal-title":"N Eng J Med"},{"key":"10.1016\/j.xjidi.2026.100499_bib5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaci.2012.04.038","article-title":"Multiple-checkpoint inhibition of thymic stromal lymphopoietin-induced TH2 response by TH17-related cytokines","volume":"130","author":"Bogiatzi","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.xjidi.2026.100499_bib6","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jaci.2023.04.009","article-title":"The neglected twin: nummular eczema is a variant of atopic dermatitis with codominant TH2\/TH17 immune response","volume":"152","author":"B\u00f6hner","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.xjidi.2026.100499_bib7","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.jaci.2017.01.011","article-title":"The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies","volume":"139","author":"Brunner","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.xjidi.2026.100499_bib8","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/ajd.13846","article-title":"Dupilumab-associated psoriasis and psoriasiform dermatitis in patients with atopic dermatitis","volume":"63","author":"Casale","year":"2022","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.xjidi.2026.100499_bib9","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1016\/j.jaip.2020.06.064","article-title":"Mixed profile of cytokines in paradoxical eczematous eruptions associated with anti-IL-17 therapy","volume":"8","author":"Chicharro","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.xjidi.2026.100499_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41467-017-02466-4","article-title":"TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis","volume":"9","author":"Conrad","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.xjidi.2026.100499_bib11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12016-018-8668-1","article-title":"Psoriasis: from pathogenesis to targeted therapies","volume":"54","author":"Conrad","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.xjidi.2026.100499_bib12","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1093\/hmg\/ddx328","article-title":"Exome-wide association study reveals novel psoriasis susceptibility locus at TNFSF15 and rare protective alleles in genes contributing to type I IFN signalling","volume":"26","author":"Dand","year":"2017","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.xjidi.2026.100499_bib13","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1038\/s41467-025-56719-8","article-title":"GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets","volume":"16","author":"Dand","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.xjidi.2026.100499_bib14","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1111\/jdv.16293","article-title":"Baricitinib-induced paradoxical psoriasis","volume":"34","author":"Di Domizio","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.xjidi.2026.100499_bib16","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jaci.2016.07.013","article-title":"Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin","volume":"138","author":"Esaki","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.xjidi.2026.100499_bib17","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/ng.3985","article-title":"Shared genetic origin of asthma, hay fever and eczema elucidates allergic disease biology","volume":"49","author":"Ferreira","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.xjidi.2026.100499_bib18","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2147\/CCID.S522469","article-title":"Successful treatment of cutaneous foreign body granuloma with jak inhibitor abrocitinib and prednisone: a case report","volume":"18","author":"Fu","year":"2025","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.xjidi.2026.100499_bib19","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1038\/s41467-025-59340-x","article-title":"An unbiased tissue transcriptome analysis identifies potential markers for skin phenotypes and therapeutic responses in atopic dermatitis","volume":"16","author":"Fukushima-Nomura","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.xjidi.2026.100499_bib20","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2012.07.012","article-title":"Progressive activation of T(H)2\/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis","volume":"130","author":"Gittler","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.xjidi.2026.100499_bib21","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.xjidi.2026.100499_bib22","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1073\/pnas.1416922112","article-title":"IL-4 abrogates TH17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells","volume":"112","author":"Guenova","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.xjidi.2026.100499_bib23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jdcr.2015.07.014","article-title":"Bullous pemphigoid during ustekinumab therapy","volume":"1","author":"Guern","year":"2015","journal-title":"JAAD Case Reports"},{"key":"10.1016\/j.xjidi.2026.100499_bib24","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/ng.2438","article-title":"Genome-wide association study identifies eight new susceptibility loci for atopic dermatitis in the Japanese population","volume":"44","author":"Hirota","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.xjidi.2026.100499_bib25","doi-asserted-by":"crossref","DOI":"10.1172\/JCI179436","article-title":"Rapid response of lichen planus to baricitinib associated with suppression of cytotoxic CXCL13+CD8+ T cells","volume":"135","author":"Hwang","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1016\/j.xjidi.2026.100499_bib26","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature06116","article-title":"Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide","volume":"449","author":"Lande","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.xjidi.2026.100499_bib27","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.jid.2024.05.015","article-title":"Paradoxical psoriasis: an updated review of clinical features, pathogenesis, and treatment options","volume":"144","author":"Maronese","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.xjidi.2026.100499_bib28","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1013068","article-title":"Interleukin-36\u2013receptor antagonist deficiency and generalized pustular psoriasis","volume":"365","author":"Marrakchi","year":"2011","journal-title":"N Eng J Med"},{"key":"10.1016\/j.xjidi.2026.100499_bib29","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1089\/derm.2023.0315","article-title":"Paradoxical eczematous eruptions in patients with psoriasis treated with biological therapy","volume":"35","author":"Michelucci","year":"2024","journal-title":"Dermatitis"},{"key":"10.1016\/j.xjidi.2026.100499_bib30","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/all.15921","article-title":"Development of a clinical algorithm to predict phenotypic switches between atopic dermatitis and psoriasis (the \u201cFlip-Flop\u201d phenomenon)","volume":"79","author":"M\u00fcller","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.xjidi.2026.100499_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13142","article-title":"Occurrence of psoriasiform eruption during dupilumab therapy for adult atopic dermatitis: a case series","volume":"32","author":"Napolitano","year":"2019","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.xjidi.2026.100499_bib32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1084\/jem.20050500","article-title":"Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production","volume":"202","author":"Nestle","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.xjidi.2026.100499_bib33","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jaci.2015.08.015","article-title":"The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization","volume":"136","author":"Noda","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.xjidi.2026.100499_bib34","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1073\/pnas.0408506102","article-title":"Cross-regulation of TNF and IFN-alpha in autoimmune diseases","volume":"102","author":"Palucka","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.xjidi.2026.100499_bib35","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/ng.3424","article-title":"Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis","volume":"47","author":"Paternoster","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.xjidi.2026.100499_bib36","series-title":"Anifrolumab-induced paradoxical psoriasis in a patient with severe cutaneous lupus: a precision medicine NanoString analysis","author":"Russo","year":"2025"},{"key":"10.1016\/j.xjidi.2026.100499_bib37","article-title":"Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib","volume":"15","author":"Salvi","year":"2024","journal-title":"Front Immunol Frontiers"},{"key":"10.1016\/j.xjidi.2026.100499_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54559-6","article-title":"Immune modules to guide diagnosis and personalized treatment of inflammatory skin diseases","volume":"15","author":"Seremet","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.xjidi.2026.100499_bib39","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.jaci.2026.01.011","article-title":"Molecular profiling of inflammatory palmoplantar disorders for diagnosis and treatment optimization","volume":"157","author":"Seremet","year":"2026","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.xjidi.2026.100499_bib40","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jdcr.2019.03.024","article-title":"Palmoplantar pustulosis\u2013like eruption following tofacitinib therapy for juvenile idiopathic arthritis","volume":"5","author":"Shibata","year":"2019","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.xjidi.2026.100499_bib41","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.jaci.2021.07.043","article-title":"Uniting biobank resources reveals novel genetic pathways modulating susceptibility for atopic dermatitis","volume":"149","author":"Sliz","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.xjidi.2026.100499_bib42","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1159\/000530608","article-title":"Dupilumab-associated psoriasis and psoriasiform manifestations: a scoping review","volume":"239","author":"Su","year":"2023","journal-title":"Dermatology"},{"key":"10.1016\/j.xjidi.2026.100499_bib43","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S0091-6749(96)80161-8","article-title":"Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study","volume":"97","author":"Thepen","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.xjidi.2026.100499_bib44","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.3390\/jcm12196291","article-title":"\u201cDe Novo\u201d psoriasis and relapse of psoriasis induced by dupilumab: three new cases and review of the literature","volume":"12","author":"Trave","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.xjidi.2026.100499_bib45","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.1038\/ncomms8001","article-title":"Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci","volume":"6","author":"Tsoi","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.xjidi.2026.100499_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15382","article-title":"Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants","volume":"8","author":"Tsoi","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.xjidi.2026.100499_bib48","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ajhg.2020.06.020","article-title":"Loss-of-function myeloperoxidase mutations are associated with increased neutrophil counts and pustular skin disease","volume":"107","author":"Vergnano","year":"2020","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.xjidi.2026.100499_bib49","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1093\/hmg\/ddt317","article-title":"A genome-wide association study of atopic dermatitis identifies loci with overlapping effects on asthma and psoriasis","volume":"22","author":"Weidinger","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.xjidi.2026.100499_bib50","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1600-0560.2006.00527.x","article-title":"Type I interferon-associated cytotoxic inflammation in lichen planus","volume":"33","author":"Wenzel","year":"2006","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.xjidi.2026.100499_bib51","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/path.1721","article-title":"Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus","volume":"205","author":"Wenzel","year":"2005","journal-title":"J Pathol"},{"key":"10.1016\/j.xjidi.2026.100499_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1709423","article-title":"Bullous pemphigoid induced by anti-IL-23 monoclonal antibody in a psoriatic patient: a case report","volume":"12","author":"Xi","year":"2025","journal-title":"Front Med"},{"key":"10.1016\/j.xjidi.2026.100499_bib53","article-title":"Application of JAK inhibitors in paradoxical reaction through immune-related dermatoses","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.xjidi.2026.100499_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1050373","article-title":"Paradoxical phenomena of bullous pemphigoid induced and treated by identical biologics","volume":"13","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.xjidi.2026.100499_bib55","doi-asserted-by":"crossref","first-page":"7489","DOI":"10.1038\/s41467-022-35209-1","article-title":"Single-cell sequencing shows cellular heterogeneity of cutaneous lesions in lupus erythematosus","volume":"13","author":"Zheng","year":"2022","journal-title":"Nat Commun"}],"container-title":["JID Innovations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667026726000524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667026726000524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:18:28Z","timestamp":1791019108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667026726000524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2667026726000524"],"URL":"https:\/\/doi.org\/10.1016\/j.xjidi.2026.100499","relation":{},"ISSN":["2667-0267"],"issn-type":[{"value":"2667-0267","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune shifts in inflammatory skin diseases","name":"articletitle","label":"Article Title"},{"value":"JID Innovations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xjidi.2026.100499","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}],"article-number":"100499"}}